Lipidomic characterization of kidney cancer tissues using HILIC-HPLC/ESI-MS
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F14%3A39899337" target="_blank" >RIV/00216275:25310/14:39899337 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Lipidomic characterization of kidney cancer tissues using HILIC-HPLC/ESI-MS
Original language description
Kidney cancer is one of the most common tumors both for men and women. Renal cell carcinoma (RCC) represents more than 90% of kidney cancer cases. Similarly to tumors of other primary locations, early detection of RCC and subsequent therapy increases thechance of cure. Lipid metabolism plays an important role in the oxidative stress and is associated with kidney cancer risk factors. The principal function of kidney is the filtration of blood and the excretion of excessive compounds and metabolites frombody through urine. The HPLC/MS characterization of lipidomic differences between kidney cancer tissues and surrounding normal tissues is the first step, which is then followed by the search for these lipids with different expression in body fluids of kidney cancer patients compared to healthy volunteers.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
CB - Analytical chemistry, separation
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů